Trump’s tariff threats and Kennedy’s anti-vaccine stance makes US a hostile environment for pharma companies ...

Gabii sa Kabilin (GSK) blooms into its 18th year this 2025, a relevant and timely theme is set to drive a vibrant and ...

CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a ...

GSK PLC GSK shares advanced 2.13% to £14.84 Tuesday, on what proved to be an all-around positive trading session for the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

For the first time, the U.S. Department of Agriculture has confirmed the presence of H5N1 avian influenza in rats, raising ...

To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...

Martin has since learned that shingles is caused by the reactivation of the varicella zoster virus, the same virus that ...

GSK PLC closed 20.35% short of its 52-week high of £18.24, which the company achieved on May 16th.

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

(HealthDay News) — The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), ...